Annual Non Current Assets
$487.70 K
-$728.00 K-59.88%
31 December 2023
Summary:
Oncolytics Biotech annual long term assets is currently $487.70 thousand, with the most recent change of -$728.00 thousand (-59.88%) on 31 December 2023. During the last 3 years, it has risen by +$10.00 thousand (+2.09%). ONCY annual non current assets is now -91.92% below its all-time high of $6.03 million, reached on 31 December 2002.ONCY Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$998.50 K
-$49.90 K-4.76%
30 September 2024
Summary:
Oncolytics Biotech quarterly long term assets is currently $998.50 thousand, with the most recent change of -$49.90 thousand (-4.76%) on 30 September 2024. Over the past year, it has increased by +$445.30 thousand (+80.50%). ONCY quarterly non current assets is now -84.83% below its all-time high of $6.58 million, reached on 31 March 2003.ONCY Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCY Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.9% | +80.5% |
| 3 y3 years | +2.1% | +27.3% |
| 5 y5 years | +61.0% | +56.0% |
ONCY Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -59.9% | +2.1% | -17.9% | +104.7% |
| 5 y | 5 years | -59.9% | +61.0% | -17.9% | +159.2% |
| alltime | all time | -91.9% | +105.5% | -84.8% | +397.3% |
Oncolytics Biotech Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $998.50 K(-4.8%) |
| June 2024 | - | $1.05 M(+3.6%) |
| Mar 2024 | - | $1.01 M(+107.6%) |
| Dec 2023 | $28.78 M(+9.4%) | $487.70 K(-11.8%) |
| Sept 2023 | - | $553.20 K(-24.5%) |
| June 2023 | - | $732.70 K(-7.1%) |
| Mar 2023 | - | $788.90 K(-35.1%) |
| Dec 2022 | $26.29 M(-25.3%) | $1.22 M(+120.6%) |
| Sept 2022 | - | $551.10 K(-14.6%) |
| June 2022 | - | $645.60 K(-11.5%) |
| Mar 2022 | - | $729.50 K(-4.7%) |
| Dec 2021 | $35.22 M(+33.1%) | $765.50 K(-2.4%) |
| Sept 2021 | - | $784.10 K(+11.7%) |
| June 2021 | - | $702.00 K(+7.4%) |
| Mar 2021 | - | $653.50 K(+36.8%) |
| Dec 2020 | $26.46 M(+82.6%) | $477.70 K(-11.8%) |
| Sept 2020 | - | $541.40 K(+40.6%) |
| June 2020 | - | $385.20 K(-15.6%) |
| Mar 2020 | - | $456.60 K(-18.0%) |
| Dec 2019 | $14.49 M(+36.6%) | $556.90 K(-13.0%) |
| Sept 2019 | - | $639.90 K(-12.3%) |
| June 2019 | - | $729.70 K(-9.4%) |
| Mar 2019 | - | $805.00 K(+165.7%) |
| Dec 2018 | $10.61 M(-25.1%) | $303.00 K(-8.7%) |
| Sept 2018 | - | $331.70 K(+17.8%) |
| June 2018 | - | $281.50 K(+2.0%) |
| Mar 2018 | - | $275.90 K(+4.0%) |
| Dec 2017 | $14.17 M(+32.3%) | $265.20 K(-3.9%) |
| Sept 2017 | - | $276.00 K(+1.0%) |
| June 2017 | - | $273.20 K(+20.8%) |
| Mar 2017 | - | $226.10 K(-4.7%) |
| Dec 2016 | $10.71 M(-44.8%) | $237.30 K(-6.6%) |
| Sept 2016 | - | $254.00 K(-11.9%) |
| June 2016 | - | $288.20 K(-9.1%) |
| Mar 2016 | - | $317.20 K(-4.3%) |
| Dec 2015 | $19.40 M(+35.1%) | $331.40 K(+0.3%) |
| Sept 2015 | - | $330.30 K(-12.3%) |
| June 2015 | - | $376.80 K(-3.6%) |
| Mar 2015 | - | $390.90 K(-13.6%) |
| Dec 2014 | $14.36 M(-44.8%) | $452.60 K(-7.0%) |
| Sept 2014 | - | $486.90 K(+10.5%) |
| June 2014 | - | $440.70 K(-4.3%) |
| Mar 2014 | - | $460.30 K(-8.0%) |
| Dec 2013 | $26.01 M(+19.4%) | $500.10 K(-9.3%) |
| Sept 2013 | - | $551.30 K(+14.1%) |
| June 2013 | - | $483.20 K(+22.8%) |
| Mar 2013 | - | $393.50 K(-4.4%) |
| Dec 2012 | $21.78 M | $411.40 K(-5.5%) |
| Sept 2012 | - | $435.20 K(+5.1%) |
| June 2012 | - | $414.20 K(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $397.20 K(+3.4%) |
| Dec 2011 | $34.90 M(-19.7%) | $384.10 K(+47.8%) |
| Sept 2011 | - | $259.80 K(+10.0%) |
| June 2011 | - | $236.20 K(-76.1%) |
| Mar 2011 | - | $988.40 K(+2.7%) |
| Dec 2010 | $43.46 M(+32.0%) | $962.40 K(+10.5%) |
| Sept 2010 | - | $870.80 K(+2.1%) |
| June 2010 | - | $852.60 K(-1.7%) |
| Mar 2010 | - | $867.20 K(+2.4%) |
| Dec 2009 | $32.93 M(+199.6%) | $846.80 K(+313.3%) |
| Sept 2009 | - | $204.90 K(+2.0%) |
| June 2009 | - | $200.80 K(-25.5%) |
| Mar 2009 | - | $269.60 K(-25.3%) |
| Dec 2008 | $10.99 M(-57.1%) | $360.90 K(-24.2%) |
| Sept 2008 | - | $476.20 K(-18.8%) |
| June 2008 | - | $586.30 K(-88.4%) |
| Mar 2008 | - | $5.07 M(+580.4%) |
| Dec 2007 | $25.60 M(+5.4%) | $744.80 K(-85.9%) |
| Sept 2007 | - | $5.29 M(+5.9%) |
| June 2007 | - | $5.00 M(+9.6%) |
| Mar 2007 | - | $4.56 M(+1.7%) |
| Dec 2006 | $24.30 M(-31.1%) | $4.48 M(-4.0%) |
| Sept 2006 | - | $4.67 M(-1.2%) |
| June 2006 | - | $4.72 M(+3.6%) |
| Mar 2006 | - | $4.56 M(+0.0%) |
| Dec 2005 | $35.27 M(+23.9%) | $4.56 M(-14.3%) |
| Sept 2005 | - | $5.32 M(+23.4%) |
| June 2005 | - | $4.31 M(-2.5%) |
| Mar 2005 | - | $4.42 M(+0.8%) |
| Dec 2004 | $28.47 M(+76.3%) | $4.39 M(+6.1%) |
| Sept 2004 | - | $4.13 M(+8.7%) |
| June 2004 | - | $3.80 M(+0.7%) |
| Mar 2004 | - | $3.77 M(-3.4%) |
| Dec 2003 | $16.15 M(+201.8%) | $3.91 M(+0.3%) |
| Sept 2003 | - | $3.90 M(+3.4%) |
| June 2003 | - | $3.77 M(-42.7%) |
| Mar 2003 | - | $6.58 M(+9.1%) |
| Dec 2002 | $5.35 M(-43.4%) | $6.03 M(+1.5%) |
| Sept 2002 | - | $5.94 M(-3.5%) |
| June 2002 | - | $6.16 M(+136.4%) |
| Mar 2002 | - | $2.61 M(+4.5%) |
| Dec 2001 | $9.45 M(-20.3%) | $2.49 M(-0.7%) |
| Sept 2001 | - | $2.51 M(-1.7%) |
| June 2001 | - | $2.55 M(+4.9%) |
| Mar 2001 | - | $2.44 M(-5.4%) |
| Dec 2000 | $11.86 M(+276.1%) | $2.57 M(+0.3%) |
| Sept 2000 | - | $2.57 M(-2.4%) |
| June 2000 | - | $2.63 M(+0.6%) |
| Mar 2000 | - | $2.61 M |
| Dec 1999 | $3.15 M | - |
FAQ
- What is Oncolytics Biotech annual long term assets?
- What is the all time high annual non current assets for Oncolytics Biotech?
- What is Oncolytics Biotech annual non current assets year-on-year change?
- What is Oncolytics Biotech quarterly long term assets?
- What is the all time high quarterly non current assets for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly non current assets year-on-year change?
What is Oncolytics Biotech annual long term assets?
The current annual non current assets of ONCY is $487.70 K
What is the all time high annual non current assets for Oncolytics Biotech?
Oncolytics Biotech all-time high annual long term assets is $6.03 M
What is Oncolytics Biotech annual non current assets year-on-year change?
Over the past year, ONCY annual long term assets has changed by -$728.00 K (-59.88%)
What is Oncolytics Biotech quarterly long term assets?
The current quarterly non current assets of ONCY is $998.50 K
What is the all time high quarterly non current assets for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly long term assets is $6.58 M
What is Oncolytics Biotech quarterly non current assets year-on-year change?
Over the past year, ONCY quarterly long term assets has changed by +$445.30 K (+80.50%)